Author: Rylee Wilson

More than 1 million people have been disenrolled from Medicaid as part of the redeterminations process, according to KFF. 

CMS' proposed rules to improve drug price transparency in Medicaid is a "positive step" toward controlling costs, Kate McEvoy, executive director of the National Association of Medicaid Directors, told Becker's. 

A top Centene executive plans to retire next year, and the company is divesting its non-core businesses. 

HHS Secretary Xavier Becerra is urging states to do more to prevent people from losing Medicaid coverage for procedural reasons. 

North Carolina Gov. Roy Cooper signed a bill allowing Blue Cross Blue Shield of North Carolina to reorganize as a nonprofit holding company.

New GLP-1 drugs to treat diabetes and obesity can be expensive, and most payers do not cover drugs only for weight loss for their members. 

HHS has added 25 drugs to its list of products eligible for Inflation Reduction Act rebates. 

Independence Blue Cross' Keystone Health Plan East received an estimated $11.3 million in overpayments for 2016 and 2017, according to an audit from HHS' Office of Inspector General. 

New York City's comptroller is halting implementation of an Aetna Medicare Advantage plan for retired city employees while the contract is challenged in court. 

Federal lawmakers are continuing to raise concerns about insurers' use of algorithms and AI to approve or deny claims.